Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ovarian Neoplasms × enzalutamide × Clear all

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 84 Metastatic Castration Resistant Prostate Cancer 9 Breast Neoplasms 9 Neoplasms 8 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Prostate Cancer Metastatic 4 Castration-resistant Prostate Cancer 4 Metastatic Castration-resistant Prostate Cancer 3 Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Non-metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Bulbo-Spinal Atrophy, X-Linked 2 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Seizures 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Prostate Carcinoma Metastatic to the Bone 1 Primary Dysautonomias 1 Primary Breast Cancer ER+ve 1 Pharmacokinetics of MDV3100 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-metastatic, Hormone naïve Prostate Cancer 1 Non-metastatic Prostate Cancer 1

Interventions

Carboplatin 176 Paclitaxel 175 Bevacizumab 71 Topotecan 55 liposomal doxorubicin 54 Gemcitabine 53 Cisplatin 46 Docetaxel 38 Cyclophosphamide 37 olaparib 31 Filgrastim 31 pembrolizumab 26 Doxorubicin 26 niraparib 23 Taxes 23 Drug Therapy 23 Peripheral Blood Stem Cell Transplantation 20 Etoposide 17 veliparib 15 Nivolumab 14 sargramostim 13 Surveys and Questionnaires 13 Immunoglobulin G 13 Disulfides 13 pazopanib 12 Ifosfamide 12 Albumin-Bound Paclitaxel 12 durvalumab 11 atezolizumab 11 Trabectedin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03464201 2023-02-22

GREKO III

Grupo Español de Tumores Huérfanos e Infrecuentes

Phase 2 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡